SOURCE: Axxess Pharma, Inc.

Axxess Pharma, Inc.

September 04, 2013 09:00 ET

Axxess Pharma Inc. Announces US Board Certified Cardiologist, Dr. Fred Maese as Senior Consultant

Dr. Maese Brings Forth Strong Medical Following via His Established Radio Shows

TORONTO, ON--(Marketwired - Sep 4, 2013) - Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, is pleased to announce Dr. Fred Maese, US Board-Certified Cardiologist and a member of the American College of Cardiology, has joined Axxess Pharma.

Since 1997 Dr. Maese has been practicing adult Cardiology and Internal Medicine in Dallas, Texas with expertise in general clinical cardiology, echocardiography and nuclear cardiology. Dr. Maese also has a large following on his radio shows, which cross over to the Hispanic network 'Univision.'

Daniel Bagi, M.D., President of Axxess Pharma stated: "Dr. Maese brings to AXXESS a wealth of knowledge and experience, running a successful medical practice. He also possesses a strong medical following via his radio shows. Dr. Maese will be a key component in the execution of our Business Plan."

Business Acumen: Dr. Maese was instrumental in the clinical acceptance, widespread use and business models pertaining to the Lap Band procedure for morbidly obese patients with and without cardiovascular disease who had failed conservative medical weight management. Dr. Maese also has significant experience in medical education in both radio and television, with his segment "Breakthrough Medicine" receiving an overwhelming acceptance by the public and peers on the popular show Good Morning Texas. In addition, his radio shows on Univision (a Hispanic population targeted TV channel) in Texas have also focused on an educational format pertinent to the Latin American population. This year he will launch both English and Spanish weekly radio programming on a variety of medical and other topics.

Dr. Maese is also the creator of the MyClinic affordable and convenient primary care model, started in 2011 and now in the expansion phase. This concept of primary care delivery services promotes preventive, acute and chronic care strategies for the whole family in an affordable and convenient fashion. MyClinic is poised to become a leader in the primary and preventive care services for the US population over the next three to five years.

For more information, please visit, or contact Investor Relations at (973) 351-3868.

About Axxess Pharma Inc.:

Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, - to optimal health management through improved nutritional supplements.

Safe Harbor Statement:

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.

Contact Information